通过下一代测序和功能性酶测试来诊断晚发性Tay-Sachs:从基因到酶
Ajay R Tupil1, Warwick Rivlin1, Pamela A Mccombe1
1From the School of Medicine (A.R.T., J.R.), The University of Queensland; Department of Neurology (W.R., P.A.M., R.D.H., L.V.), Royal Brisbane & Women's Hospital; The University of Queensland (P.A.M., R.D.H., L.V.), UQ Centre for Clinical Research; and Genetic Health Queensland (J.R.), Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia.
Neurology. Genetics
|January 14, 2025
概括
晚期发病的泰-萨克斯病 (LOTS) 可以呈现出逐渐减弱和缺氧. 诊断包括对HEXA基因和功能性酶试验的基因测试,即使在成年人中也是如此.
科学领域:
- 神经遗传学 神经遗传学
- 生物化学 生物化学
背景情况:
- 泰-萨克斯病是一种罕见的神经退行性疾病,通常在婴儿期出现.
- 成人发病的形式,如晚发病的Tay-Sachs (LOTS),不太常见,并且可能被误诊.
- 在HEXA基因的致病变异导致缺陷的β-hexosaminidase活动,导致团结体积累.
研究的目的:
- 报告两个成年人Tay-Sachs病例.
- 突出诊断挑战和方法,以晚期发病的演示.
- 强调基因和酶测试在确认LOTS.的作用.
主要方法:
- 两名成年患者出现神经和神经精神症状的病例报告.
- 对HEXA基因进行基因分析,以识别致病变体.
- 功能性酶检测测量测量β-hexosaminidase活动.
主要成果:
- 两位患者都表现出不同HEXA基因变异的复合异构性.
- 一名患者在基因检测后显示胺酶活性降低.
- 另一位患者在基因确认之前接受了酶测试.
- 这两种病例都呈现出渐进的虚弱,无氧和神经精神症状.
结论:
- 晚期发病的泰-萨克斯病可以在成年期表现为各种神经症状.
- 基因和功能性酶测试的结合对于诊断LOTS至关重要.
- 早期诊断和干预可能是通过识别这些替代陈述来实现的.
相关概念视频
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Pedigree Analysis
83.9K
Overview
83.9K


